US Stock MarketDetailed Quotes

MOR MorphoSys

Watchlist
  • 18.140
  • -0.040-0.22%
Close Mar 27 16:00 ET
  • 18.090
  • -0.050-0.28%
Pre 04:55 ET
2.73BMarket Cap-11989P/E (TTM)

About MorphoSys Company

MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

Company Profile

SymbolMOR
Company NameMorphoSys
Listing Date04/19/2018
Issue Price25.04
Founded1992
CEOMr. Jean-Paul Kress
MarketNASDAQ
Employees524
Securities TypeDR
ADS Ratio4.0 : 1.0
Fiscal Year Ends12-31
AddressSemmelweisstrasse 7
CityPlanegg
ProvinceBayern (Bavaria)
CountryGermany
Zip Code82152
Phone49-89-89927-0

Company Executives

  • Name
  • Position
  • Salary
  • Jean-Paul Kress
  • Chief Executive Officer
  • 5.03M
  • Lucinda Crabtree
  • Chief Financial Officer
  • --
  • Dr. George Golumbeski, PhD
  • Deputy Chairman of the Supervisory Board
  • 100.10K
  • Dr. Marc Cluzel, M.D.,PhD
  • Chaiman of the Supervisory Board
  • 149.40K
  • Michael Brosnan
  • Member of the Supervisory Board
  • 91.30K
  • Sharon Evelyn Curran
  • Member of the Supervisory Board
  • 72.50K
  • Krisja Vermeylen
  • Member of the Supervisory Board
  • 89.30K
  • Dr. Andrew Cheng, M.D.,PhD
  • Member of the Supervisory Board
  • 40.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg